Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sentara Norfolk General Hospital
• Collaborator: Veloxis Pharmaceuticals
• Treatments: Tacrolimus

Criteria

Inclusion Criteria:

• Age 18-70

• Receiving a kidney transplant at Sentara Norfolk General Hospital

• Able to give informed consent

Exclusion Criteria:

• Multi-organ transplant

• Previous functioning transplant

• Prior surgery to the gastrointestinal tract that alters the normal anatomy with the exception of cholecystectomy

• Women of childbearing potential who cannot or are unwilling to maintain adequate contraception during the course of this study.